Page 167 - scheppingen

MIR147B: A NOVEL KEY REGULATOR OF IL-1β-MEDIATED INFLAMMATION IN ASTROCYTES
DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
25. Cline MS, Smoot M, Cerami E, et al. Integration of biological networks and gene expression data
using Cytoscape. Nat Protoc. 2007;2(10):2366-82.
26. Chatterjee V, Beard RS, Jr., Reynolds JJ, et al. MicroRNA-147b regulates vascular endothelial barrier
function by targeting ADAM15 expression. PloS one. 2014;9(10):e110286.
27. Liu G, Friggeri A, Yang Y, Park Y-J, Tsuruta Y, Abraham E. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proceedings
of the National Academy of Sciences of the United States of America. 2009;106:15819-24.
28. Zhang Y, Zhang HE, Liu Z. MicroRNA-147 suppresses proliferation, invasion and migration through
the AKT/mTOR signaling pathway in breast cancer. Oncol Lett. 2016 Jan;11(1):405-10.
29. Lee CG, McCarthy S, Gruidl M, Timme C, Yeatman TJ. MicroRNA-147 induces a mesenchymal-to-ep-
ithelial transition (MET) and reverses EGFR inhibitor resistance. PloS one. 2014;9(1):e84597.
30. Omrane I, Kourda N, Stambouli N, et al. MicroRNAs 146a and 147b biomarkers for colorectal
tumor’s localization. Biomed Res Int. 2014;2014:584852.
31. Podolin PL, Callahan JF, Bolognese BJ, et al. Attenuation of murine collagen-induced arthritis by a
novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl) amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation. J Pharmacol Exp Ther. 2005 Jan;312(1):373-81.
32. Nan J, Du Y, Chen X, et al. TPCA-1 is a direct dual inhibitor of STAT3 and NF-kappaB and regresses mutant EGFR-associated human non-small cell lung cancers. Mol Cancer Ther. 2014 Mar;13(3):617-29.
33. Sun C, Wu MH, Lee ES, Yuan SY. A disintegrin and metalloproteinase 15 contributes to athero- sclerosis by mediating endothelial barrier dysfunction via Src family kinase activity. Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2444-51.
34. van Vliet EA, da Costa Araujo S, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain. 2007 Feb;130(Pt 2):521-34.
35. Peterson TR, Laplante M, Thoreen CC, et al. DEPTOR is an mTOR inhibitor frequently overex-
pressed in multiple myeloma cells and required for their survival. Cell. 2009;137:873-86.
36. van Vliet EA, Forte G, Holtman L, et al. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation. Epilepsia. 2012
Jul;53(7):1254-63.
37. Citraro R, Leo A, Constanti A, Russo E, De Sarro G. mTOR pathway inhibition as a new therapeutic
strategy in epilepsy and epileptogenesis. Pharmacol Res. 2016 May;107:333-43.
38. Baulac S. mTOR signaling pathway genes in focal epilepsies. Prog Brain Res. 2016;226:61-79.
39. Desjardins P, Sauvageau A, Bouthillier A, et al. Induction of astrocytic cyclooxygenase-2 in epileptic
patients with hippocampal sclerosis. Neurochem Int. 2003 Mar;42(4):299-303.
40. Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by acti-
vated microglia. Nature. 2017 Jan 26;541(7638):481-7.
41. Uhlmann EJ, Wong M, Baldwin RL, et al. Astrocyte-specific TSC1 conditional knockout mice exhibit
abnormal neuronal organization and seizures. Ann Neurol. 2002 Sep;52(3):285-96.
42. Ortinski PI, Dong J, Mungenast A, et al. Selective induction of astrocytic gliosis generates deficits
in neuronal inhibition. Nat Neurosci. 2010 May;13(5):584-91.
43. Nguyen LS, Lepleux M, Makhlouf M, et al. Profiling olfactory stem cells from living patients identi-
fies miRNAs relevant for autism pathophysiology. Mol Autism. 2016;7:1.
44. Mei J, Bachoo R, Zhang CL. MicroRNA-146a inhibits glioma development by targeting Notch1. Mol
Cell Biol. 2011 Sep;31(17):3584-92.
45. Kanski R, van Strien ME, van Tijn P, Hol EM. A star is born: new insights into the mechanism of
astrogenesis. Cell Mol Life Sci. 2014 Feb;71(3):433-47.
46. Boer K, Jansen F, Nellist M, et al. Inflammatory processes in cortical tubers and subependymal
giant cell tumors of tuberous sclerosis complex. Epilepsy Res. 2008 Jan;78(1):7-21.
47. Weaver DF, Pohlmann-Eden B. Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s).
Epilepsia. 2013 May;54 Suppl 2:80-5.
165
six